A prospective study to evaluate the reduction of PD-L1 expression due to sample age in patients with non-small cell lung cancer

A prospective study to evaluate the reduction of PD-L1 expression due to sample age in patients with non-small cell lung cancer - A prospective study to evaluate PD-L1 expression due to sample age in patients with non-small cell lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030356

Enrollment

Registered

2017-12-11

Start date

2017-11-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Age of 20 years old and older than 20 years old. 2)Histologically and/or cytologically proven non-small cell lung cancer. 3)Sufficient tumor cells in tissue specimens to evaluate PD-L1 expression (over 100 Viable tumor cells). 4)PD-L1 expression has been evaluated within 3 months of tumor tissue harvest.

Exclusion criteria

Exclusion criteria: 1)Dementia or psychological disorder difficult to participate in this clinical study.

Design outcomes

Primary

Measure	Time frame
PD-L1 expression in tumor tissue one year after first evaluation	—

Countries

Japan

Contacts

Public ContactKawachi Hayato

Kobe city medical center general hospital Respiratory medicine

kwhat0729@gmail.com078-302-4321

Outcome results